High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer (Q39028165)

8 September 2017

title

High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer (English)

1 reference

8 September 2017

1 reference

Caiyun Zhou

1 reference

8 September 2017

Peng Zuo

1 reference

8 September 2017

Yuejiang Ma

1 reference

8 September 2017

Yongjie Huang

1 reference

8 September 2017

Feng Ye

1 reference

8 September 2017

Pei Wang

1 reference

8 September 2017

Xinyu Wang

1 reference

8 September 2017

Weiguo Lu

1 reference

8 September 2017

Beihua Kong

1 reference

8 September 2017

Xing Xie

1 reference

8 September 2017

language of work or name

English

0 references

publication date

31 January 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

132

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

745-751

1 reference

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

The biology of ovarian cancer: new opportunities for translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

GMF is a cofilin homolog that binds Arp2/3 complex to stimulate filament debranching and inhibit actin nucleation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

The expression of glia maturation factors and the effect of glia maturation factor-γ on angiogenic sprouting in zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Overexpression of glia maturation factor (GMF) in PC12 pheochromocytoma cells activates p38 MAP kinase, MAPKAP kinase-2, and tyrosine hydroxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

In vitro enhancement of p38 mitogen-activated protein kinase activity by phosphorylated glia maturation factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Activation of nuclear factor-kappaB in C6 rat glioma cells after transfection with glia maturation factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Glia maturation factor gamma regulates the migration and adherence of human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Glia maturation factor-γ mediates neutrophil chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Notch3 gene amplification in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Cancer metastasis: building a framework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Axis of evil: molecular mechanisms of cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Cell migration: integrating signals from front to back

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Regulation of the actin cytoskeleton in cancer cell migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

The ARP2/3 complex: an actin nucleator comes of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.01.044

10.1016/J.YGYNO.2014.01.044

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference